The bioavailability of acyclovir to the ophthalmic epithelium is low a
nd when the drug is administered in ophthalmic ointment it must be app
lied every four hours. An emulsification technique has been used to pr
epare acyclovir-loaded chitosan microspheres with the aim of promoting
the prolonged release of drug and increasing its ocular bioavailabili
ty. The microparticulate drug-delivery systems obtained have been char
acterized for their morphology and physicochemical characteristics by
in-vitro dissolution tests and in-vivo ocular administration to rabbit
s. The results show that the microspheres obtained are always quite sm
all-the diameters of 90% of the particles are less than or equal to 25
mu m (i.e. d(90%) never exceeds 25 mu m) and physicochemical characte
rization shows that the drug is homogeneously dispersed in an amorphou
s state inside the microspheres. The in-vitro dissolution profile of a
cyclovir from chitosan microspheres is slower than that for the raw dr
ug. Results from in-vivo ocular administration of acyclovir-loaded mic
rospheres to the rabbit eye show prolonged high concentrations of acyc
lovir and increased AUC values. The microparticulate drug-carrier seem
s a promising means of topical administration of acyclovir to the eye.